ATS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Ann Thorac Surg 2008;86:1524-1529. doi:10.1016/j.athoracsur.2008.06.075
© 2008 The Society of Thoracic Surgeons

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Author home page(s):
Daniel Zimpfer
Ernst Weigang
Michael Grimm
Martin Czerny
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Gottardi, R.
Right arrow Articles by Czerny, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Gottardi, R.
Right arrow Articles by Czerny, M.
Related Collections
Right arrow Great vessels


Original Articles: Adult Cardiac

Supra-aortic Transposition for Combined Vascular and Endovascular Repair of Aortic Arch Pathology

Roman Gottardi, MDa, Martin Funovics, MDb, Nella Eggersa, Alexander Hirner, MSa, Marion Dorfmeister, MDa, Johannes Holfelda, Daniel Zimpfer, MDa, Maria Schoder, MDb, Konstantin Donas, MDa, Ernst Weigang, MDc, Johannes Lammer, MDb, Michael Grimm, MDa, Martin Czerny, MDa,*

a Department of Cardiothoracic Surgery, University of Vienna Medical School, Vienna, Austria
b Department of Interventional Radiology, University of Vienna Medical School, Vienna, Austria
c Department of Cardiothoracic and Vascular Surgery, University Hospital Mainz, Mainz, Germany

Accepted for publication June 13, 2008.

* Address correspondence to Dr Czerny, Waehringer Guertel 18-20, Vienna, A-1090, Austria (Email: martin.czerny{at}meduniwien.ac.at).

Presented at the Poster Session of the Forty-fourth Annual Meeting of The Society of Thoracic Surgeons, Fort Lauderdale, FL, Jan 28–30, 2008.

Background: Supra-aortic transpositions in various extents followed by endovascular stent graft placement are now an established tool in the treatment of various pathologies affecting the aortic arch. Results remain to be determined.

Methods: From 1996 through 2007, 73 patients (median age, 71 years) presented with aortic arch pathology (atherosclerotic aneurysms, n = 42; type B dissections, n = 9; penetrating ulcers, n = 17; traumatic lesions, n = 2; aneurysms based on prior surgery for aortic coarctation, n = 3). Strategy for distal arch disease was subclavian-to-carotid transposition (n = 24) or autologous double-vessel transposition through upper hemisternotomy (n = 36). For entire arch disease, total supra-aortic rerouting with a reversed bifurcated prosthesis was applied (n = 13). Endovascular stent graft placement was performed metachronously.

Results: In-hospital mortality was 6.8% (n = 5). Persistent early type I and III endoleak rate was 9.6%. Persistent late type I and III endoleak rate was 5.5%. Overall actuarial survival was 90%, 86%, and 72% at 1, 3, and 5 years. Mean follow-up is 37 months (range, 1 to 120). Early and late endoleak formation was independently predicted by the number of prostheses (early odds ratio [OR] 0.210, p = 0.0003; late OR 0.216, p = 0.012), whereas logistic EuroSCORE (European System for Cardiac Operative Risk Evaluation) reached borderline significance regarding late endoleaks (OR 2.1, p = 0.095). An earlier year of implantation reached borderline significance predicting survival (OR 1.9, p = 0.062). Furthermore, survival was independently predicted by higher logistic EuroSCORE levels (OR 1.8, p = 0.020). Interestingly, type of arch rerouting did not influence endoleak formation and survival (OR 0.9, p = 0.812).

Conclusions: Results after supra-aortic transpositions in various extents followed by endovascular stent graft placement for the treatment of various pathology affecting the aortic arch are promising. Endoleak formation is directly related to the number of prostheses and may be reduced by longer devices. Each type of arch rerouting, irrespective of extent, has turned out to be effective. Therefore, extended applications of these combined treatment strategies substantially augment the therapeutic options.




This article has been cited by other articles:


Home page
Ann. Thorac. Surg.Home page
G. C. Hughes, M. A. Daneshmand, K. R. Balsara, H. A. Achneck, B. Sileshi, S. M. Lee, and R. L. McCann
"Hybrid" Repair of Aneurysms of the Transverse Aortic Arch: Midterm Results
Ann. Thorac. Surg., December 1, 2009; 88(6): 1882 - 1888.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
K. Tsagakis, M. Kamler, H. Kuehl, W. Kowalczyk, P. Tossios, M. Thielmann, B. Osswald, R. Erbel, H. Eggebrecht, and H. Jakob
Avoidance of proximal endoleak using a hybrid stent graft in arch replacement and descending aorta stenting.
Ann. Thorac. Surg., September 1, 2009; 88(3): 773 - 779.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
I. Schuster, M. Dorfmeister, S. Scheuter-Mlaker, R. Gottardi, M. Hoebartner, S. Roedler, T. Dziodzio, A. Juraszek, C. Loewe, M. Funovics, et al.
Endovascular and Conventional Treatment of Thoracic Aortic Aneurysms: A Comparison of Costs.
Ann. Thorac. Surg., June 1, 2009; 87(6): 1801 - 1805.e6.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 2008 by The Society of Thoracic Surgeons.